These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 17389761

  • 21. ZNF198, a zinc finger protein rearranged in myeloproliferative disease, localizes to the PML nuclear bodies and interacts with SUMO-1 and PML.
    Kunapuli P, Kasyapa CS, Chin SF, Caldas C, Cowell JK.
    Exp Cell Res; 2006 Nov 15; 312(19):3739-51. PubMed ID: 17027752
    [Abstract] [Full Text] [Related]

  • 22. B-lymphoblastic leukemia/lymphoma associated with t(8;13)(p11;q12)/ ZMYM2 (ZNF198)-FGFR1 : rare case and review of the literature.
    Trimaldi J, Carballido EM, Bowers JW, Anguiano AL, Zhang ZJ, Shah BD, Bruno S, List AF, Moscinski LC, Grady T, Agosti SJ, Kang L, Zhang L.
    Acta Haematol; 2013 Nov 15; 130(3):127-34. PubMed ID: 23594707
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Clonal evolution of 8p11 stem cell syndrome in a 14-year-old Chinese boy: a review of literature of t(8;13) associated myeloproliferative diseases.
    Wong WS, Cheng KC, Lau KM, Chan NP, Shing MM, Cheng SH, Chik KW, Li CK, Ng MH.
    Leuk Res; 2007 Feb 15; 31(2):235-8. PubMed ID: 16777224
    [Abstract] [Full Text] [Related]

  • 26. The genomic structure of ZNF198 and location of breakpoints in the t(8;13) myeloproliferative syndrome.
    Kulkarni S, Reiter A, Smedley D, Goldman JM, Cross NC.
    Genomics; 1999 Jan 01; 55(1):118-21. PubMed ID: 9889006
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Myeloproliferative neoplasms with t(8;22)(p11.2;q11.2)/BCR-FGFR1: a meta-analysis of 20 cases shows cytogenetic progression with B-lymphoid blast phase.
    Montenegro-Garreaud X, Miranda RN, Reynolds A, Tang G, Wang SA, Yabe M, Wang W, Fang L, Bueso-Ramos CE, Lin P, Medeiros LJ, Lu X.
    Hum Pathol; 2017 Jul 01; 65():147-156. PubMed ID: 28551329
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [The 8p11 myeloproliferative syndrome].
    Reither A, Hehlmann R, Goldman JM, Cross NC.
    Med Klin (Munich); 1999 Apr 15; 94(4):207-10. PubMed ID: 10373756
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. 8p11 myeloproliferative syndrome preceded by t(8;9)(p11;q33), CEP110/FGFR1 fusion transcript: morphologic, molecular, and cytogenetic characterization of myeloid neoplasms associated with eosinophilia and FGFR1 abnormality.
    Park TS, Song J, Kim JS, Yang WI, Song S, Kim SJ, Suh B, Choi JR.
    Cancer Genet Cytogenet; 2008 Mar 15; 181(2):93-9. PubMed ID: 18295660
    [Abstract] [Full Text] [Related]

  • 39. The t(8;17)(p11;q23) in the 8p11 myeloproliferative syndrome fuses MYO18A to FGFR1.
    Walz C, Chase A, Schoch C, Weisser A, Schlegel F, Hochhaus A, Fuchs R, Schmitt-Gräff A, Hehlmann R, Cross NC, Reiter A.
    Leukemia; 2005 Jun 15; 19(6):1005-9. PubMed ID: 15800673
    [Abstract] [Full Text] [Related]

  • 40. A ZMYM2-FGFR1 8p11 myeloproliferative neoplasm with a novel nonsense RUNX1 mutation and tumor lysis upon imatinib treatment.
    Buijs A, van Wijnen M, van den Blink D, van Gijn M, Klein SK.
    Cancer Genet; 2013 Apr 15; 206(4):140-4. PubMed ID: 23751892
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.